This study found that various tRFs were enriched in hearts with cardiac hypertrophy, with tRF-Glu-CTC-013 acting as a biological marker and exhibiting functions that reduce inflammation, myocardial hypertrophy, and fibrosis. This evidence concerns the gene TERF1 and cardiac hypertrophy.